High Potential Soil Anomalies Strengthen Discovery Outlook at Needles Gold Project

Venari Minerals NL (ASX: VMS) has reported highly encouraging results from a comprehensive soil sampling program at its Needles Gold Project in Nevada, USA, reinforcing the project’s large-scale epithermal gold-silver discovery potential. The 820-point sampling campaign delineated six significant multi-element soil anomalies characterized by strong gold and arsenic associations, along with elevated silver, antimony, and mercury values—key indicators of epithermal mineralization. Most anomalies are situated near mapped faults and intersections, highlighting structurally controlled mineralization zones, with none having been drill-tested to date.

These findings significantly expand Venari’s exploration pipeline, identifying multiple untested targets. The Company is currently interpreting results from a recent airborne magnetic-radiometric survey and awaiting delayed assay results from an eight-hole RC drilling program, expected in the coming weeks. Executive Chairman Tony Leibowitz emphasized the strong geochemical signatures and the substantial untapped exploration upside across the Needles Project.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com